Skip to ContentSkip to Navigation
How to find us dr. F.E. Reesink


Amyloid burden quantification depends on PET and MR image processing methodology

Emotion Recognition and Traffic-Related Risk-Taking Behavior in Patients with Neurodegenerative Diseases

Feasibility of pharmacokinetic parametric PET images in scaled subprofile modelling using principal component analysis

Temporal dynamics of depression, cognitive performance and sleep in older persons with depressive symptoms and cognitive impairments: a series of eight single-subject studies

Widespread white matter aberration is associated with the severity of apathy in amnestic Mild Cognitive Impairment: Tract-based spatial statistics analysis

Uptake and effectiveness of a tailor-made online lifestyle programme targeting modifiable risk factors for dementia among middle-aged descendants of people with recently diagnosed dementia: study protocol of a cluster randomised controlled trial (Demin study)

Alzheimer's disease pattern derived from pharmacokinetic modeling of 11C-Pittsburgh compound B PET scans

Biomarkers in the differential diagnosis of dementia: cerebrospinal fluid compounds- and nuclear molecular imaging tracers

Correction: Relative cerebral flow from dynamic PIB scans as an alternative for FDG scans in Alzheimer's disease PET studies

Diagnostic performance of regional cerebral blood flow images derived from dynamic PIB scans in Alzheimer's disease

Read more